Skip to main content

Anebulo Pharmaceuticals Inc. Common Stock (ANEB)

About The Company

ANEB Stock Market Logo

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.

IPO Year Sector Industry
2021 Health Care Biotechnology: Pharmaceutical Preparations

Anebulo Pharmaceuticals Inc. (ANEB) Latest News

Company Contact & Address (ANEB)

Corporate Headquarters Phone Website
United States
+1 512 598-0931 Official ANEB Website

ANEB Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ ANEB

Jobs & Employment at Anebulo Pharmaceuticals Inc.

LinkedIn Company Page
Official Career & Employment Page See LinkedIn page for the employment & jobs details.

Related & Similar Stock Symbols

GLBE Stock Market Price & News


Global-E Online Ltd. Ordinary Shares

XPRO Stock Market Price & News


Expro Group Holdings N.V. Common Stock

PROV Stock Market Price & News


Provident Financial Holdings Inc. Common Stock